Lv11
18 积分 2025-07-30 加入
Investigating the Metabolic Mechanisms of Butaselen, An Ebselen Analog
6小时前
已完结
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
11个月前
已完结
Abstract 2830: Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with a combination of PARP and ATR inhibitors
11个月前
已关闭
SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway
11个月前
已完结
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism
11个月前
已完结
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers
11个月前
已完结
A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers
1年前
已完结
Discovery of 1H-Pyrrolo[2,3-b]pyridine Derivatives as Highly Selective, and Orally Available ATM Inhibitors with Potent In Vivo Antitumor Activity
1年前
已完结
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity
1年前
已完结
Abstract 2943: Novel combination therapy of DNMT inhibitor SGI-110 and PARP inhibitor BMN-673 (talazoparib) for BRCA-proficient ovarian cancer
1年前
已完结
皖公网安备34019202002308
